Jinmei Li

1.1k total citations · 1 hit paper
37 papers, 795 citations indexed

About

Jinmei Li is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Jinmei Li has authored 37 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in Jinmei Li's work include Gut microbiota and health (4 papers), RNA modifications and cancer (4 papers) and Circular RNAs in diseases (4 papers). Jinmei Li is often cited by papers focused on Gut microbiota and health (4 papers), RNA modifications and cancer (4 papers) and Circular RNAs in diseases (4 papers). Jinmei Li collaborates with scholars based in China, United States and Canada. Jinmei Li's co-authors include Zhang Zhen-qiu, Hui Li, Jian Zhou, Zhifeng Chen, Mingfeng Xu, Jay Sanjayan, Song Nie, Mingzhang Lan, Zhixiong Yang and Shuiqiao Yuan and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.

In The Last Decade

Jinmei Li

32 papers receiving 779 citations

Hit Papers

Analysis of theoretical carbon dioxide emissions from cem... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinmei Li China 13 351 191 146 107 104 37 795
Jia Q. Ng Australia 14 281 0.8× 240 1.3× 72 0.5× 84 0.8× 228 2.2× 23 1.2k
Gege Chen China 14 242 0.7× 144 0.8× 69 0.5× 50 0.5× 97 0.9× 43 607
Xingxing Hu China 19 208 0.6× 85 0.4× 70 0.5× 128 1.2× 16 0.2× 76 949
Yuanyuan Yang China 13 164 0.5× 97 0.5× 53 0.4× 57 0.5× 20 0.2× 32 617
Mujib Rahman United Kingdom 21 235 0.7× 511 2.7× 89 0.6× 15 0.1× 179 1.7× 35 1.1k
Jiejing Chen China 16 111 0.3× 274 1.4× 53 0.4× 36 0.3× 87 0.8× 51 630
Takatoshi Nawa Japan 13 88 0.3× 405 2.1× 71 0.5× 52 0.5× 66 0.6× 36 745
Weiguo Xu China 14 344 1.0× 31 0.2× 217 1.5× 58 0.5× 46 0.4× 67 683
Daniel Svensson Sweden 19 217 0.6× 167 0.9× 73 0.5× 125 1.2× 4 0.0× 47 895

Countries citing papers authored by Jinmei Li

Since Specialization
Citations

This map shows the geographic impact of Jinmei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinmei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinmei Li more than expected).

Fields of papers citing papers by Jinmei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinmei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinmei Li. The network helps show where Jinmei Li may publish in the future.

Co-authorship network of co-authors of Jinmei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jinmei Li. A scholar is included among the top collaborators of Jinmei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinmei Li. Jinmei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jinmei, et al.. (2025). Decoding UTROSCT heterogeneity: systematic clinicopathological evaluation combined with molecular profiling. The Journal of Pathology Clinical Research. 12(1). e70055–e70055.
2.
Zhan, Ying, Kaiming Wang, Jinmei Li, et al.. (2025). Synergistic action of non-digestible xylooligosaccharide and Lactiplantibacillus plantarum ZDY2013 against high fat diet and streptozocin-induced type 2 diabetes mellitus in rats. Microbiological Research. 297. 128174–128174. 2 indexed citations
3.
4.
Li, Jinmei, et al.. (2025). Peiminine Alleviates Breast Carcinoma via Reprogramming the PI3K/Akt/mTOR Pathway in vitro and in vivo. Indian Journal of Pharmaceutical Education and Research. 59(1). 210–220. 1 indexed citations
5.
Feng, Shenglei, Shi Yin, Xinxin Xiong, et al.. (2024). Histone demethylase KDM2A recruits HCFC1 and E2F1 to orchestrate male germ cell meiotic entry and progression. The EMBO Journal. 43(19). 4197–4227. 4 indexed citations
8.
Li, Jinmei, et al.. (2023). Long noncoding RNA LINC00482 silencing sensitizes non-small cell lung cancer cells to cisplatin by downregulating CLASRP via E2F1. Functional & Integrative Genomics. 23(4). 335–335. 1 indexed citations
9.
Zhou, Hang, et al.. (2022). The Efficacy and Safety of the Zhuyun Formula and Auricular Acupressure for the Infertile Women with Recurrent Implantation Failure: A Randomized Controlled Trial. Evidence-based Complementary and Alternative Medicine. 2022. 1–15. 2 indexed citations
10.
Wang, Xiaoli, Jinmei Li, & Shuiqiao Yuan. (2022). Characterization of the protein expression and localization of hnRNP family members during murine spermatogenesis. Asian Journal of Andrology. 25(3). 314–321. 10 indexed citations
11.
Li, Jinmei, Shenglei Feng, Xixiang Ma, Shuiqiao Yuan, & Xiaoli Wang. (2022). METTL21A, a Non-Histone Methyltransferase, Is Dispensable for Spermatogenesis and Male Fertility in Mice. International Journal of Molecular Sciences. 23(4). 1942–1942. 3 indexed citations
12.
Li, Jinmei, et al.. (2022). Therapeutic Effect of Bone Marrow Mesenchymal Stem Cells on Rat Bladder Cancer. 6(6). 15–20. 1 indexed citations
13.
Feng, Shenglei, Jinmei Li, Hui Wen, et al.. (2022). hnRNPH1 recruits PTBP2 and SRSF3 to modulate alternative splicing in germ cells. Nature Communications. 13(1). 3588–3588. 39 indexed citations
14.
Li, Jimin, Yaowen Li, Xiaoyu Guo, et al.. (2021). Synthesis and Anti-tumor Effects of Naphthalimide Derivatives Targeted in Cell Nucleus. Chinese Journal of Organic Chemistry. 41(4). 1599–1599. 2 indexed citations
15.
Xu, Jiao, Juan Xu, Jinmei Li, et al.. (2021). Health-Related Quality of Life and Its Influencing Factors for Elderly Patients With Hypertension: Evidence From Heilongjiang Province, China. Frontiers in Public Health. 9. 654822–654822. 29 indexed citations
16.
Li, Jinmei, Gonghong Yan, Tong Jiang, et al.. (2017). Target of rapamycin complex 1 and Tap42‐associated phosphatases are required for sensing changes in nitrogen conditions in the yeast Saccharomyces cerevisiae. Molecular Microbiology. 106(6). 938–948. 6 indexed citations
17.
Su, Wenmei, et al.. (2016). miR-135b reverses chemoresistance of non-small cell lung cancer cells by downregulation of FZD1. Biomedicine & Pharmacotherapy. 84. 123–129. 42 indexed citations
18.
Zhang, Yingmei, Zhuo Zhang, Jinmei Li, et al.. (2012). Long‐term efficacy and safety of arsenic trioxide for first‐line treatment of elderly patients with newly diagnosed acute promyelocytic leukemia. Cancer. 119(1). 115–125. 32 indexed citations
19.
Xiao, Fei, Xuefeng Wang, Jinmei Li, et al.. (2008). Overexpression of N-WASP in the brain of human epilepsy. Brain Research. 1233. 168–175. 24 indexed citations
20.
Wang, Jing, et al.. (2007). Inhibitory effect of artesunate on human esophageal carcinoma is associated with CDC25A modulation. Di-san junyi daxue xuebao. 428–431. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026